Select Publications
Book Chapters
2017, 'Therapeutic drug monitoring: More than avoiding toxicity', in Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill, pp. 173 - 199, http://dx.doi.org/10.1007/978-981-10-5336-8_9
,Journal articles
2024, 'A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease', British Journal of Clinical Pharmacology, 90, pp. 2529 - 2538, http://dx.doi.org/10.1111/bcp.16139
,2024, 'Full Validation and Application to Clinical Research of a High-Performance Liquid Chromatography Method for the Assessment of Urinary 3-Indoxyl Sulfate in Pediatric Patients with Hematopoietic Stem Cell Transplant', Methods and Protocols, 7, http://dx.doi.org/10.3390/mps7040064
,2024, 'Crying Over Stark Differences: Resource Disparity and Therapeutic Drug Monitoring', Therapeutic Drug Monitoring, 46, pp. 415 - 416, http://dx.doi.org/10.1097/FTD.0000000000001185
,2024, 'Very high linezolid clearance in a critically ill patient: A case report suggesting a novel metabolic induction mechanism', International Journal of Antimicrobial Agents, 63, http://dx.doi.org/10.1016/j.ijantimicag.2024.107170
,2023, 'Ceftazidime Plasma Concentrations and Neurotoxicity: The Importance of Therapeutic Drug Monitoring in Patients Undergoing Different Modalities of Renal Replacement Therapy. A Grand Round', Therapeutic Drug Monitoring, 45, pp. 711 - 713, http://dx.doi.org/10.1097/FTD.0000000000001124
,2023, 'It cuts both ways: A single-center retrospective review describing a three-way interaction between flucloxacillin, voriconazole and tacrolimus', International Journal of Antimicrobial Agents, 62, http://dx.doi.org/10.1016/j.ijantimicag.2023.106908
,2023, 'Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patients', Medical Journal of Australia, 218, pp. 441 - 444, http://dx.doi.org/10.5694/mja2.51937
,2023, 'The Placental Function Beyond Pregnancy: Insights from Latin America', , 1428, pp. 287 - 307, http://dx.doi.org/10.1007/978-3-031-32554-0_13
,2022, 'The evidence synthesis and meta-analysis in R conference (ESMARConf): levelling the playing field of conference accessibility and equitability', Systematic Reviews, 11, http://dx.doi.org/10.1186/s13643-022-01985-6
,2022, 'Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.959741
,2022, 'Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey', Frontiers in Pharmacology, 13, http://dx.doi.org/10.3389/fphar.2022.992354
,2022, 'Better pharmacovigilance through artificial intelligence: What is needed to make this a reality?', Health Policy and Technology, 11, http://dx.doi.org/10.1016/j.hlpt.2022.100638
,2022, 'Estrogen rapid effects: A window of opportunity for the aging brain?', Neural Regeneration Research, 17, pp. 1629 - 1632, http://dx.doi.org/10.4103/1673-5374.332121
,2022, 'Perfectionism, academic stress and social anxiety in female medical students and the risk for eating disorders', Revista Medica de Chile, 150, pp. 1046 - 1053, http://dx.doi.org/10.4067/S0034-98872022000801046
,2022, 'Covid-19 research evidence: An international survey exploring views on useful sources, preferred formats, and accessibility', Journal of Evidence-Based Healthcare, 4, pp. e4010 - e4010, http://dx.doi.org/10.17267/2675-021xevidence.2022.e4010
,2022, 'Cannabis-based medicines for prevention of postoperative nausea and vomiting in adults', Cochrane Database of Systematic Reviews, 2022, http://dx.doi.org/10.1002/14651858.CD014567
,2022, 'Understanding the Pharmacokinetics of Antibiotics in Pregnancy: Is There a Role for Therapeutic Drug Monitoring? A Narrative Review', Therapeutic Drug Monitoring, 44, pp. 50 - 64, http://dx.doi.org/10.1097/FTD.0000000000000950
,2022, 'Immunosenescence, viral infections and nutrition: A narrative review of scientific available evidence', Revista Espanola de Geriatria y Gerontologia, 57, pp. 33 - 38, http://dx.doi.org/10.1016/j.regg.2021.08.003
,2021, 'Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients', Frontiers in Pharmacology, 12, http://dx.doi.org/10.3389/fphar.2021.674117
,2021, 'Efficacy of methadone for the management of postoperative pain in laparoscopic cholecystectomy: A randomized clinical trial', Medwave, 21, http://dx.doi.org/10.5867/medwave.2021.02.8134
,2021, 'Diet and depressive disorders', Revista de Psiquiatria Clinica, 48, pp. 117 - 122, http://dx.doi.org/10.15761/0101-60830000000290
,2020, 'Stakeholders' perceptions of humanized birth practices and obstetric violence in Chile: A scoping review', Medwave, 20, http://dx.doi.org/10.5867/medwave.2020.09.8047
,2020, 'Cluster C personality traits and attention deficit disorder in medical students. An analytical cross-sectional study', Revista Medica de Chile, 148, pp. 1105 - 1112, http://dx.doi.org/10.4067/S0034-98872020000801105
,2020, 'How to design a study to evaluate therapeutic drug monitoring in infectious diseases?', Clinical Microbiology and Infection, 26, pp. 1008 - 1016, http://dx.doi.org/10.1016/j.cmi.2020.03.008
,2020, 'The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients – a retrospective study', Transplant International, 33, pp. 936 - 947, http://dx.doi.org/10.1111/tri.13624
,2020, 'In vitro susceptibility of chilean cryptococcus neoformans strains of clinical source', Revista Chilena de Infectologia, 37, pp. 124 - 128, http://dx.doi.org/10.4067/s0716-10182020000200124
,2020, 'Placental structure in gestational diabetes mellitus', Biochimica et Biophysica Acta - Molecular Basis of Disease, 1866, http://dx.doi.org/10.1016/j.bbadis.2019.165535
,2020, 'A cross-sectional study on the characteristics and factors associated with the clinical course of child and adolescent patients hospitalized in a public child and adolescent psychiatric unit of Chile', Medwave, 20, http://dx.doi.org/10.5867/medwave.2020.02.7853
,2020, 'Chilean legislation on bioequivalence and biosimilarity and current controversies related to drug interchangeability', Medwave, 20, http://dx.doi.org/10.5867/medwave.2020.01.7825
,2020, 'General concepts in biostatistics and clinical epidemiology: Experimental studies with randomized clinical trial design', Medwave, 20, http://dx.doi.org/10.5867/medwave.2020.02.7869
,2020, 'Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review', Expert Opinion on Drug Safety, pp. 873 - 890, http://dx.doi.org/10.1080/14740338.2020.1770224
,2019, 'General concepts in biostatistics and clinical epidemiology: observational studies with case-control design', Medwave, 19, http://dx.doi.org/10.5867/medwave.2019.10.7716
,2019, 'General concepts in biostatistics and clinical epidemiology: Observational studies with cross-sectional and ecological designs', Medwave, 19, http://dx.doi.org/10.5867/medwave.2019.08.7698
,2019, 'Using systematic reviews in the scientific substantiation of health properties of foods and food constituents', Medwave, 19, http://dx.doi.org/10.5867/medwave.2019.06.7664
,2019, 'Default mode network, meditation, and age-associated brain changes: What can we learn from the impact of mental training on well-being as a psychotherapeutic approach?', Neural Plasticity, 2019, http://dx.doi.org/10.1155/2019/7067592
,2018, 'Corneal endothelial cell loss associated to phacoemulsification and ophthalmologist experience: prospective analysis of individual secondary data', Medwave, 18, pp. e7314, http://dx.doi.org/10.5867/medwave.2018.06.7314
,2016, 'Erratum: Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses (Pharmacological Research (2015) 101 (124-129) DOI: 10.1016/j.phrs.2015.07.020)', Pharmacological Research, 110, pp. 276, http://dx.doi.org/10.1016/j.phrs.2016.04.019
,2016, 'A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation', Pharmacogenomics, 17, pp. 375 - 391, http://dx.doi.org/10.2217/pgs.15.181
,2016, 'Genetic polymorphisms in the immune response: A focus on kidney transplantation', Clinical Biochemistry, 49, pp. 363 - 376, http://dx.doi.org/10.1016/j.clinbiochem.2015.07.016
,2016, 'Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections', International Journal of Antimicrobial Agents, 47, pp. 124 - 131, http://dx.doi.org/10.1016/j.ijantimicag.2015.12.003
,2016, 'New challenges and promises in solid organ transplantation pharmacogenetics: The genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs', Pharmacogenomics, 17, pp. 277 - 296, http://dx.doi.org/10.2217/pgs.15.169
,2015, 'Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses', Pharmacological Research, 101, pp. 124 - 129, http://dx.doi.org/10.1016/j.phrs.2015.07.020
,2015, 'Naturaleza, desastres y política: entrevista a Manuel Tironi', Revista Chilena de Salud Pública, 19, pp. 83 - 83, http://dx.doi.org/10.5354/0719-5281.2015.36388
,2014, 'Salud pública como investigación universitaria de posgrado', Revista Chilena de Salud Pública, 18, pp. 292 - 292, http://dx.doi.org/10.5354/0719-5281.2014.33998
,2014, 'Isapre más allá del Enactment: un Hangout con José Ossandón', Revista Chilena de Salud Pública, 18, pp. 210 - 210, http://dx.doi.org/10.5354/0719-5281.2014.31985
,2014, 'Luc Delannoy, director del Instituto de Neuroartes, Tijuana, México', Revista Chilena de Salud Pública, 18, pp. 95 - 95, http://dx.doi.org/10.5354/0719-5281.2014.30761
,2014, 'Luc Delannoy, director del Instituto de Neuroartes, Tijuana, México', Revista Chilena de Salud Pública, 18, http://dx.doi.org/10.5354/0717-3652.2014.30761
,2014, 'Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?', Frontiers in Genetics, 5, http://dx.doi.org/10.3389/fgene.2014.00391
,2011, 'Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants', Pharmacological Research, 63, pp. 1 - 7, http://dx.doi.org/10.1016/j.phrs.2010.10.016
,